Blood-Based Circular RNAs Enable Early and Accurate Alzheimer’s Disease Diagnosis
Preprint
- 9 December 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Detection of Alzheimer’s disease (AD) prior to the development of clinical symptoms is critical due to new treatments for symptomatic AD. Circular RNAs (circRNAs) are highly stable non-coding RNAs enriched in brain that can cross the blood-brain-barrier and are associated with AD. Using two large and independent whole-blood transcriptomic datasets, we identified 34 circRNAs associated with clinical AD status. A single-cutoff predictive model including these 34 circRNAs was comparable to plasma pTau217 in classifying AD based on clinical or AT status, that replicated in the independent dataset. The circRNAs (Hazard Ratio (HR): 2.92) outperformed pTau217 (HR: 1.81) and amyloid-PET when predicting progression to symptomatic AD. CircRNA levels began diverging 4–8 years before symptom onset, enabling preclinical risk stratification. The circRNA model was specific for AD showing low predictive power for PD, DLB, and FTD. These results establish blood circRNAs as robust biomarkers in AD diagnosis and disease progression.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population AncestryJAMA Neurology, 2023
- Sex Differences in Alzheimer’s DiseaseNeurologic Clinics, 2023
- Identification of circRNAs linked to Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2023
- Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassaysAlzheimer's & Dementia, 2022
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- Time from diagnosis to institutionalization and death in people with dementiaAlzheimer's & Dementia, 2020
- Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer’s disease patientsMetabolic Brain Disease, 2019
- Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedMolecular Cell, 2015
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyThe Lancet Neurology, 2013
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991